248 related articles for article (PubMed ID: 37004784)
21. Hypoxia alleviating platinum(IV)/chlorin e6-based combination chemotherapeutic-photodynamic nanomedicine for oropharyngeal carcinoma.
Paul M; Itoo AM; Ghosh B; Biswas S
J Photochem Photobiol B; 2023 Jan; 238():112627. PubMed ID: 36525775
[TBL] [Abstract][Full Text] [Related]
22. Photosensitizer-conjugated Cu-In-S heterostructured nanorods for cancer targeted photothermal/photodynamic synergistic therapy.
Chen SH; Huang WW; Dehvari K; Ling YC; Ghule AV; Tsai SL; Chang JY
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():793-802. PubMed ID: 30678970
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticulate photosensitizer decorated with hyaluronic acid for photodynamic/photothermal cancer targeting therapy.
Wang X; Ouyang X; Chen J; Hu Y; Sun X; Yu Z
Nanomedicine (Lond); 2019 Jan; 14(2):151-167. PubMed ID: 30511886
[TBL] [Abstract][Full Text] [Related]
24. Carrier Free O
Huang JQ; Zhao LP; Zhou X; Liu LS; Zheng RR; Deng FA; Liu YB; Yu XY; Li SY; Cheng H
Small; 2022 Apr; 18(15):e2107467. PubMed ID: 35224854
[TBL] [Abstract][Full Text] [Related]
25. Platelet-mimicking supramolecular nanomedicine with precisely integrated prodrugs for cascade amplification of synergistic chemotherapy.
Ding YF; Wang Z; Kwong CHT; Zhao Y; Mok GSP; Yu HZ; Wang R
J Control Release; 2023 Aug; 360():82-92. PubMed ID: 37331605
[TBL] [Abstract][Full Text] [Related]
26. Carrier free nanomedicine to reverse anti-apoptosis and elevate endoplasmic reticulum stress for enhanced photodynamic therapy.
Zhou X; Li Y; Li X; Huang J; Kong R; Liu L; Cheng H
Acta Biomater; 2022 Oct; 152():507-518. PubMed ID: 36030050
[TBL] [Abstract][Full Text] [Related]
27. Supramolecular Nanoparticles of Histone and Hyaluronic Acid for Co-Delivery of siRNA and Photosensitizer In Vitro.
Hu M; Bao J; Zhang Y; Wang L; Zhang Y; Zhang J; Tang J; Zou Q
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791462
[TBL] [Abstract][Full Text] [Related]
28. Self-delivery biomedicine for enhanced photodynamic therapy by feedback promotion of tumor autophagy.
Chen SY; Zhao LP; Chen ZX; Huang CY; Kong RJ; Wang YQ; Zhang DW; Li SY; Ti HH; Cheng H
Acta Biomater; 2023 Mar; 158():599-610. PubMed ID: 36603734
[TBL] [Abstract][Full Text] [Related]
29. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
[TBL] [Abstract][Full Text] [Related]
30. A nanosensitizer self-assembled from oleanolic acid and chlorin e6 for synergistic chemo/sono-photodynamic cancer therapy.
Zheng Y; Li Z; Yang Y; Shi H; Chen H; Gao Y
Phytomedicine; 2021 Dec; 93():153788. PubMed ID: 34634745
[TBL] [Abstract][Full Text] [Related]
31. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
He H; Du L; Xue H; Wu J; Shuai X
Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
[TBL] [Abstract][Full Text] [Related]
32. Thiolated hyaluronic acid and catalase-enhanced CD44-targeting and oxygen self-supplying nanoplatforms with photothermal/photodynamic effects against hypoxic breast cancer cells.
Wang XY; Lin C; Chang WJ; Huang YH; Mi FL
Int J Biol Macromol; 2022 Nov; 221():121-134. PubMed ID: 36049568
[TBL] [Abstract][Full Text] [Related]
33. Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy.
Ding L; Lin X; Lin Z; Wu Y; Liu X; Liu J; Wu M; Zhang X; Zeng Y
ACS Appl Mater Interfaces; 2020 Aug; 12(33):36906-36916. PubMed ID: 32706242
[TBL] [Abstract][Full Text] [Related]
34. pH-responsive and self-targeting assembly from hyaluronic acid-based conjugate toward all-in-one chemo-photodynamic therapy.
Wu J; Hu X; Liu R; Zhang J; Song A; Luan Y
J Colloid Interface Sci; 2019 Jul; 547():30-39. PubMed ID: 30933691
[TBL] [Abstract][Full Text] [Related]
35. Chlorin e6: A Promising Photosensitizer in Photo-Based Cancer Nanomedicine.
Hak A; Ali MS; Sankaranarayanan SA; Shinde VR; Rengan AK
ACS Appl Bio Mater; 2023 Feb; 6(2):349-364. PubMed ID: 36700563
[TBL] [Abstract][Full Text] [Related]
36. Tumor homing-penetrating and nanoenzyme-augmented 2D phototheranostics against hypoxic solid tumors.
Wu C; Zhang Y; Wei X; Li N; Huang H; Xie Z; Zhang H; Yang G; Li M; Li T; Yang H; Li S; Qin X; Liu Y
Acta Biomater; 2022 Sep; 150():391-401. PubMed ID: 35917909
[TBL] [Abstract][Full Text] [Related]
37. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
[TBL] [Abstract][Full Text] [Related]
38. Chlorin e6-EGF conjugated gold nanoparticles as a nanomedicine based therapeutic agent for triple negative breast cancer.
Castilho ML; Jesus VPS; Vieira PFA; Hewitt KC; Raniero L
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102186. PubMed ID: 33497816
[TBL] [Abstract][Full Text] [Related]
39. Construction and Evaluation of a Targeted Hyaluronic Acid Nanoparticle/Photosensitizer Complex for Cancer Photodynamic Therapy.
Gao S; Wang J; Tian R; Wang G; Zhang L; Li Y; Li L; Ma Q; Zhu L
ACS Appl Mater Interfaces; 2017 Sep; 9(38):32509-32519. PubMed ID: 28875691
[TBL] [Abstract][Full Text] [Related]
40. Self-delivery nanomedicine for vascular disruption-supplemented chemo-photodynamic tumor therapy.
Liu Y; Deng F; Zheng R; Chen X; Zhao L; Yu B; Chen A; Jiang X; Cheng H; Li S
J Colloid Interface Sci; 2022 Apr; 612():562-571. PubMed ID: 35026565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
